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Abstract 
Background & Aims: Gastrointestinal symptom-specific fear and anxiety are important 
determinants of gastrointestinal symptom perception.  This study aimed to study fear learning 
towards innocuous gastrointestinal sensations as a putative mechanism in the development of 
gastrointestinal symptom-specific fear and anxiety. 
 
Methods: Fifty-two healthy subjects (26 women) received 2 types of esophageal balloon 
distentions at a perceptible but non-painful intensity (conditioned stimulus [CS], the 
innocuous sensation) and at a painful intensity (unconditioned stimulus [US]). Subjects were 
randomly assigned to 1 of 2 groups. . During the learning phase, the innocuous CS preceded 
the painful US in the experimental group (n=26). In the control group (n=26), on the contrary, 
the US never followed the CS directly. During a subsequent extinction phase, both groups 
received only CS distentions—the painful US was no longer administered. Indexes of fear 
learning towards the innocuous CS distention included the skin conductance response, fear-
potentiated startle (measured by the eyeblink electromyogram), and self-reported expectancy 
of the US. 
 
Results: During the learning phase, only the experimental group learned to fear the innocuous 
gastrointestinal CS, based on the increase in US expectancy (compared to the control group, 
P=.04), increased skin conductance response (compared to the control group, P=.03), and 
potentiated startle reflex (compared to the control group, P=.001) in response to the CS. The 
differences between experimental and control groups in US expectancy and skin conductance, 
but not fear-potentiated startle, disappeared during the extinction phase. 
 
Conclusions: Fear towards innocuous gastrointestinal sensations can be established through 
associative learning in healthy humans. This may be an important mechanism in the 
development of fear of gastrointestinal symptoms, implicated in the pathophysiology of 
functional gastrointestinal disorders. 
 
 
KEY WORDS: functional gastro-intestinal disorders; visceral pain; interoceptive 
conditioning; gastrointestinal symptom-specific fear 
  
Accepted manuscript for Clinical Gastroenterology & Hepatology 
4 
 
Introduction 
 
Visceral pain is one of the primary causes for seeking medical attention and the most common 
form of pain resulting from disease1. Gastrointestinal symptoms, including visceral pain, often 
occur without the presence of any detectable physiological abnormalities, as is the case in 
functional gastrointestinal disorders (FGID). 
Stress-related affective and cognitive psychobiological processes play an important 
role in the pathophysiology of FGID through the brain-gut axis, the bidirectional 
neurohumoral communication system between the central nervous system and the 
gastrointestinal tract
2,3
. Gastrointestinal symptom-specific fear, the apprehension of specific 
visceral sensations, is one of the most important cognitive-affective processes in this 
context
4,5
 as it is associated with symptom severity and quality of life in FGID, specifically in 
irritable bowel syndrome (IBS)
6
. Furthermore, decreases in gastrointestinal symptom-specific 
fear mediates the effect of exposure-based cognitive behavioral therapy on IBS symptoms
7,8
. 
How gastrointestinal symptom-specific fear develops remains unclear, but it is often 
assumed that fear learning plays a key role in its development. More specifically, originally 
benign visceral sensations may become associated with unpleasant or painful visceral 
sensations. For example, benign, non-painful epigastric sensations may precede an episode of 
stomach ache. As a consequence of this temporal contingency, the individual eventually 
experiences these benign sensations as unpleasant and may come to fear them, whereas before 
the same sensations were experienced as relatively neutral. This natural learning process is a 
case of Pavlovian aversive conditioning in which a relatively neutral stimulus becomes a 
conditioned stimulus (CS) predicting the inherently unpleasant unconditioned stimulus (US). 
When both the benign CS and the painful US are experienced at the same anatomical location 
as in the example above, this is referred to as homoreflexive conditioning. When either the CS 
or US, or both, are perceived as informative about the internal state of the body, i.e. 
interoceptive, this is referred to as interoceptive conditioning
9
. Homoreflexive interoceptive 
fear conditioning is an interesting candidate mechanism in the development and maintenance 
of gastrointestinal symptom-specific fear, but to the best of our knowledge, this has not been 
directly studied
10–12
. 
 The purpose of the current study was therefore to study fear learning towards innocuous 
visceral sensations as a potential mechanism in the development of gastrointestinal symptom-
specific fear. In order to address this void in the current knowledge, we set up a study with a 
painful esophageal stimulus as US, and a detectable, non-painful esophageal stimulus as CS. 
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We expected fear learning to the CS to occur when the CS immediately precedes the painful 
US (experimental group), but not when the CS and US are separated by a relatively long time 
interval (control group). 
 
 Materials and Methods 
Subjects 
Fifty-two healthy participants (26 women) were recruited via advertisements on social 
media. Interested individuals received an informed consent in line with the declaration of 
Helsinki prior to deciding whether or not to participate (more details in Supplementary 
Material). Participants were randomly assigned to the experimental or the control group (see 
later). Both groups were matched for age and gender.  
 
 Esophageal Stimulation 
Both the CS and US consisted of mechanical stimulation of the distal, autonomously 
innervated part of the esophagus
13
. The CS and the US lasted 5 and 2 seconds, respectively. 
The intensity of stimulation was individually determined for both CS and US using a variation 
of the ascending methods of limits, with the CS being perceptible but non-painful stimulation 
of the esophagus, and the US being painful but still bearable stimulation at the same 
anatomical site (more details in Supplementary Material). A pediatric catheter (used for 
gavage) with a diameter of 3mm (TR-2008, Pennine©) was inserted via the nose into the 
distal esophagus, 35 cm from the nostril. A deflated custom made, silicon medical balloon 
(diameter: 5mm, length: 25mm, Medasil©) was firmly attached to the end of the catheter 
positioned in the esophagus (more details in Supplementary Material).  
  
 Subjective expectancy of US onset 
 Throughout the study, participants posed their dominant hand on a custom-built 
dial
14,15
, continuously rating the extent to which they expected the US in the following 
seconds. The scale of the dial ranged from 0 to 100. A score in the middle (50) meant the 
participant totally did not know whether or not to expect the US. The more certain they were 
that the US would not come, the more participants turned the dial below 50 and towards zero. 
The more certain they were to expect the US, the more they turned the dial from 50 upwards 
to 100. More details are provided in Supplementary Material. 
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 Psychophysiological measures 
Eyeblink startle EMG 
The startle eyeblink reflex is a brief increase in activation of the muscle surrounding 
the eye, which can be elicited using a sudden burst of sound. The magnitude of the elicited 
muscle activation can be used as a measure of activation subcortical fear circuits 
16
. In fear 
conditioning studies, increased startle magnitudes during the CS relative to magnitudes during 
the absence of the CS are thought to reflect motor preparation (an aspect of fear) in response 
to the CS (more details in Supplementary Material). 
 
Galvanic Skin Response  
The skin conductance response is a measure of changes in electrodermal activity. 
These changes occur in response to activation of sweat glands. Sweat gland activity increases 
as a function of increase in emotional (and/or sympathetic) arousal, with more exciting stimuli 
increasing skin conductance responses
17
. This measure was included based on the reasoning 
that an increase in skin conductance response would occur when the CS gains emotional 
significance, because participants have learned it will be followed shortly by the painful US 
(more details in Supplementary Material). 
 
Study Design 
The experiment consisted of three phases: (a) a baseline phase (4 trials), (b) a learning 
phase (16 trials), and (c) an extinction phase (16 trials).  
During the baseline and extinction phases, both groups were treated identically and 
received one innocuous CS distention in every trial, and no painful US distentions. During the 
learning phase, both groups received one innocuous CS in every trial and in addition one 
painful US in 75% of the trials (the 3
rd
, 8
th
, 11
th
, and 15
th
 trial of the learning phase had no 
US). Such partial (75%) reinforcement of the CS with the US during the learning phase is 
known to strengthen conditioning
18
. In addition, it may better reflect clinical reality compared 
to a 100% reinforcement scheme, as also in patients, not every innocuous abdominal sensation 
is always followed by a painful sensation. For the experimental group, the CS was followed 
almost immediately (with a 2s delay) by the US. The control group had an interval of 26 
seconds between the CS and the US onset (see  Figure 1). In essence, in the experimental 
group the CS announces the imminence of the painful US, whereas in the control group it 
announces an imminent 'safe' and pain-free period.  
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 Every trial lasted 48 seconds, irrespective of phase. The innocuous CS distention was 
administered always from the 15
th 
up to the 20
th 
second after trial onset. Acoustic startle 
probes occurred at the 19th second (during the CS) and the 43rd second (during the post-CS 
inter stimulus interval, ISIpostCS) of each trial (see  Figure 1). More details are provided in 
Supplementary Material. 
  
--- Please insert fig. 1 around here ----  
 
 Response definition and statistical analysis 
As US-expectancy was measured continuously, data were reduced by selecting 5 time 
points of interest for each trial: the 7
th
 second (prior to the CS, in the middle of ISIpre-CS
a
), 20
th
 
second (during the CS), 24
th
 second (end of US for the experimental group / beginning of 
ISIpost-CS for the control group), 33
rd
 second (middle of ISIpost-CS
b
) and the 45
th
 second (end of 
trial; i.e., right before US onset for the control group).  
Galvanic skin responses were calculated by subtracting the mean skin conductance 
level during “baseline” (2s before the CS onset) from the maximum value in the window 0-7 s 
following CS onset (more details in Supplementary Material).  
Eyeblink startle (EMG) responses were calculated by taking the difference between 
the peak value in the 21 - 175 ms time window and the mean value from the 0 -20 ms time 
window following probe onset (more details in Supplementary Material). 
The learning and extinction phases were subdivided into an early and late block 
comprising 8 trials each. Hypotheses were tested with planned comparisons in repeated 
measure ANOVAs with Block (baseline, early learning, late learning, early extinction, and 
late extinction) as a within-subject factor and Group (experimental, control) as a between-
subject factor. For US-expectancy, an additional within-subject factor Time was included (7
th
, 
20
th
, 24
th
, 33
rd
, 45
th
 second) with the 7
th
 second (i.e., trial onset, prior to the CS) as reference. 
For startle EMG, a within-subject factor Stimulus (CS, ISIpost-CS) was included. Greenhouse-
Geisser corrections were applied where appropriate. Uncorrected degrees of freedom and 
corrected p’s are reported together with 2
p  (as a measure of effect size) and ε (as a measure 
of sphericity). All contrasts were tested two-tailed. Alpha was set at .05. All statistical 
analyses were performed using SPSS 20.  
                                                          
a
ISIpre-cs = Inter Stimulus Interval from trial onset till onset of the CS. 
b
ISIpost-cs = Inter Stimulus Interval from CS offset till US onset in the control group. 
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To test the main hypothesis that fear learning to the CS would occur and extinguish again in 
the experimental relative to the control group, we tested for each measure specific planned 
contrasts. We expected no group differences to occur during the baseline and the last 
extinction block. During the late learning block, we expected the experimental group to have 
higher skin conductance responses (GSRs) to the CS compared to the control group in the 
learning phase, because the CS announced US-imminence only in the experimental group. In 
a similar vein, we expected that participants from the experimental group would increase their 
US-expectancy during the CS (second 20 relative to second 7) to a greater extent than the 
control group in the late learning block. For the control group, the US was imminent towards 
the end of the ISIpostCS during the learning phase; therefore, we expected that only participants 
from the control group would have higher US-expectancies at second 45 relative to second 7 
during the late learning block. For startle EMG, we expected that startle potentiation during 
the CS (startle eyeblink response magnitude during the CS relative to during the ISI) would 
increase from baseline to late acquisition in the experimental group only. The result section 
reports on the planned contrasts. Findings on the omnibus tests in the repeated measure 
ANOVAs can be found in Supplementary Materials.  
 
 Results 
  US-expectancy 
  Baseline phase 
 As expected, groups did not differ in their increase in US-expectancy during the CS 
(second 20 relative to second 7) or near the end of a trial (second 45 relative to second 7), 
F(1,50) = .31, p = .58 and F(1,50) = .05, p = .83, respectively.  
 
  Learning phase 
 As expected, both groups differed in their change in US expectancy during the CS 
during the late learning phase, F(1,50) = 4.54, p = .038, 2
p =.08: the experimental group had 
a greater increase in US-expectancy during the CS (second 20 relative to second 7) compared 
the control group (see Figure 2). In addition, the increase in US-expectancy from prior to the 
CS (second 7) towards the end of the trial (second 45) was greater for the control than for the 
experimental group, F(1,50) = 6.48, p = .014, 2
p =.12 (see Figure 2). 
 
  Extinction phase 
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 During the late extinction block, group differences in US-expectancy during the CS 
(second 20 relative to second 7) and near the end of a trial (second 45 relative to second 7) 
were no longer significant, F(1,50) =.54, p = .47 and F(1,50) = .02, p = .87, respectively.  
 
--- Please insert Fig. 2 around here --- 
 
  Galvanic Skin Response 
 Baseline phase 
As expected, no group differences in skin conductance responses to the CS were observed 
during baseline F(1, 50) =.25, p = .62 (see Figure 3). 
 
  Learning phase 
 As expected, the CS elicited significantly stronger skin conductance responses in the 
experimental group compared to the control group during the late learning phase F(1,50) = 
5.72, p = .021, 2
p  = .1 (see Figure 3).  
 
 Extinction phase 
 As expected, there were no group differences during the late extinction phase, in skin 
conductance responses to the CS F(1,50) = 1.98, p = .17 (see Figure 3). 
 
--- Please insert fig. 3 around here ----  
 
 Startle eye blink EMG 
 Baseline phase 
 During the baseline phase, no group differences were observed in startle amplitudes to 
the CS relative to startle amplitudes during the ISIpost-CSF(1, 43) = 1.24, p = .27 (see Figure 
4A & 4B). 
 
  Learning phase 
 During the late learning block, a significant group difference in the startle magnitude 
during the CS relative to the ISIpost-CS was found, F(1,43) = 13.37, p =.001, 
2
p =.24, with 
higher CS amplitudes compared to ISI amplitudes in the paired group and the opposite pattern 
in the unpaired group (see Figure 4A & 4B). 
Accepted manuscript for Clinical Gastroenterology & Hepatology 
10 
 
 
  Extinction phase 
 Opposite to our hypothesis, there still was a significant group difference in startle 
amplitudes during the CS relative to the ISIpost-CS  during late extinction F(1,43) = 5.8, p = 
.020, 2
p =.12, with higher CS amplitudes compared to ISI amplitudes in the paired group and 
the opposite in the unpaired group. (see Figure 4A & 4B). 
 
--- Please insert Fig. 4 around here --- 
Discussion 
The current study sought to investigate for the first time whether fear towards 
innocuous gastrointestinal sensations can develop by means of associative learning between 
consecutive gastrointestinal events in healthy humans. To this end, a novel homoreflexive 
interoceptive conditioning paradigm was developed with experimentally induced visceral 
sensations at the level of the distal esophagus, as CS and US. The general aim of the current 
study was to assess whether associative fear learning towards innocuous gastrointestinal 
sensation can be established, as such learning processes are considered central in the 
generation and maintenance of gastrointestinal symptom-specific fear, a key factor in the 
pathophysiology of FGID. 
 
  Principal findings 
We hypothesized that fear learning to the innocuous non-painful visceral CS would be 
established by means of associative learning between interoceptive events, which should be 
reflected in increases in subjective anticipation of the US during the CS, increased skin 
conductance responses to the CS and fear potentiated startle responses in the presence of the 
CS relative to the absence of the CS. We also hypothesized that these learned fear responses 
would disappear again in the extinction phase, when the innocuous CS was no longer 
followed by the US.  
 Associative fear learning. Participants assigned to the experimental group learned to 
fear the innocuous gastrointestinal sensation (CS) during the learning phase, because for them 
it signaled the imminence of a painful gastrointestinal sensation (US). Such fear learning to 
the CS was absent in the control group for whom the innocuous sensation (CS) signaled a 
relatively safe period without pain. Importantly, fear learning to the innocuous sensation (CS) 
was established at different levels of learning and for all outcomes. The effects on US-
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expectancy indicate that in the late block of the learning phase, participants from the 
experimental group had to some extent acquired explicit knowledge of the CS-US 
contingency. In addition, the relatively increased skin conductance responses to the CS in the 
experimental compared to the control group provides evidence that the innocuous CS had 
gained emotional significance for participants from the experimental group. Finally, we found 
also fear learning effects in startle eyeblink EMG, which is generally accepted to be an index 
of covert, subcortical activation of fear circuits
16
. Together, these results convincingly 
demonstrate that fear for innocuous gastrointestinal sensations can arise from temporal 
contingencies between gastrointestinal events, giving rise to associative learning. This in turn 
can be linked to earlier hypotheses on the generation of gastrointestinal symptom-specific 
fear, which attribute an important role to associative learning processes by which initially 
relatively 'neutral' bodily sensations start provoking fear through activation of fear circuits in 
the brain
10–12
. 
 
Extinction of learned fear. Our hypothesis that fear would extinguish in the 
experimental group when the innocuous CS was no longer followed by the painful US was 
only partially confirmed. Towards the end of extinction, both groups did no longer differ in 
the skin conductance responses to or US-expectancies during the CS. Yet, the experimental 
group still responded with a fear-potentiated startle to the CS, relative to the control group. 
This is very much in line with earlier findings using respiratory sensations as CS and US in an 
interoceptive associative learning paradigm
14
. Whereas fear-conditioned changes in skin 
conductance responses and in US expectancy primarily reflect explicit knowledge of the CS–
US contingency, startle potentiation is thought to more directly reflect subcortical, amygdala-
dependent emotional learning that can dissociate from the former measures
19,20
. Our findings 
suggest that extinction of unconscious, emotional learning to visceral sensations is 
particularly slow and rather difficult to establish, and may therefore require a more in-depth 
and prolonged extinction training.    
 
  Clinical Implications  
The present findings on how fear towards innocuous gastrointestinal sensations can 
come about through an associative learning process is relevant for any gastrointestinal 
disorder but for FGID in particular, as many of those patients are characterized by excessive 
distress and fear towards certain types of gastrointestinal sensations
4
. Recently, we have 
found that associative learning leading to gastrointestinal sensations does not only cause 
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emotional distress, but also alters perceptual thresholds for those gastrointestinal sensations
13
. 
Thus, gastrointestinal symptom-specific fear and visceral hypersensitivity may be closely 
related, likely because associative learning between gastrointestinal events is a key common 
mechanism underlying both phenomena
11
.  
Our findings further support the value of exposure-based cognitive-behavioral 
treatment as an important treatment option for FGID, particularly in patients with high levels 
of gastrointestinal symptom-specific fear. Previous research found exposure-based treatment 
to be effective in symptomatic improvement of IBS, with its effects being mediated by 
reduction in gastrointestinal symptom-specific fear 
8,10
. In line with this, the present study 
confirms that extinction learning as a process is not limited to external feared objects (e.g., 
spiders), but also applies to visceral sensations and can therefore considered the major active 
ingredient of successful interoceptive exposure therapies.  
Interestingly, our findings from the extinction phase suggest that innocuous visceral 
sensations can activate subcortical emotional responses, despite one is aware that the 
sensation will not be followed by or develops into a painful sensation. Such dissociation 
between fear indices during extinction may have clinical relevance. For example, even though 
a patient may have understood from the treating MD and clearly accepts that a certain type of 
gastrointestinal sensations is not harmful and does not reflect disease activity, a patient may 
still show fear responses towards these innocuous gastrointestinal sensations, causing feelings 
of distress and potentially lowering the threshold to perceive the sensations. Therefore, in-
depth and prolonged exposure therapy may be required to extinguish learned fear responses to 
gastrointestinal sensations. 
 
  Conclusion  
 We can conclude from our study that innocuous gastrointestinal sensations can come 
to elicit fear once they have been associated to a painful sensation that shares perceptual 
similarities to the innocuous sensation and has an identical anatomical origin (i.e. in this case, 
the gastrointestinal tract). The present study demonstrated that it is possible to form an 
association between an originally benign visceral sensation and an unpleasant visceral 
sensation merely through the basic process of associative learning. Thus, the present study 
established that classical conditioning is a viable mechanism to create gastrointestinal 
symptom-specific fear, which may in turn trigger the development of FGID and maintain or 
exacerbate symptoms. Furthermore, our findings suggest that a prolonged exposure therapy 
may be necessary for an in-depth extinction of gastrointestinal symptom-specific fear. 
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 Figure legends 
  
Figure 1. Schematic illustration of trial structure during the learning phase.  
The conditioned stimulus (CS) was delivered from 15 to 20 seconds after trial onset, and 
preceded and followed by an inter-stimulus interval (ISI), respectively labeled ISIpre-cs and 
ISIpost-cs. An unconditioned stimulus (US) was delivered from 22 to 24 seconds after trial 
onset for the experimental group, and from 46 to 48 seconds for the control group. The sound 
symbols represent acoustic startle probes, which were invariably administered at 19s and 43s 
after trial onset. The black squares on the timelines are the points in time which were included 
in the analysis of the subjective US-anticipation. 
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Figure 2. Mean US-anticipation ratings at the 7
th
, 20
th
, 24
th
, 33
rd 
and 45
th
 second for the 
experimental and control group during the baseline phase, early learning phase (Early 
learn), late learning phase (Late learn), early extinction phase (Early ext) and late 
extinction phase (Late ext).  
On a 0-100 scale, a rating of ‘50’ reflects the point of uncertainty, ‘100’ reflects 100% 
certainty that the US is imminent, while ‘0’ 100% certainty that the US is not-imminent The 
light grey bars represent the presentation of the CS, the darker grey bars represent the 
presentation of the US.  
 
  
Accepted manuscript for Clinical Gastroenterology & Hepatology 
16 
 
Figure 3. Mean log transformed skin Conductance responses of the experimental and 
ccontrol group during the baseline phase, early and late learning phase, early and late 
extinction phase.  
The error bars represent the standard error.  
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Figure 4. Mean startle amplitudes (T-scores) for the (A) experimental group and the (B) 
control group .  
The error bars represent the standard error. See Results section for statistical details. CS = 
conditioned stimulus; ISI = Inter-stimulus interval (after CS); learn = learning phase; ext = 
extinction phase. 
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Supplementary Material 
 
Methods 
Subjects 
The informed consent outlined the experimental procedure including stimuli to be delivered, 
guaranteed anonymity, and stated that participation was voluntary (with a reimbursement of 
50 Euros), and mentioned that participation could be halted at any moment if the participant 
so desired, without loss of the promised reimbursement.  
If still interested, participants were required to indicate whether or not they had a 
history or presence of: (a) psychiatric conditions; (b) abdominal or thoracic surgery (except 
appendectomy and cholecystomy); (c) neurological, endocrine, or digestive disorders, and/or 
(d) other medical disorders. Moreover they also had to indicate whether at the time of the 
experiment they (e) were pregnant, (f) had pain symptoms, (g) used medication affecting the 
function of the digestive tract and/or the nervous system, (h) had a recent accident of which 
they weren’t fully recovered yet, and/or (i) had a serious hearing impairment. Anyone 
affirming any or several of these, was deemed unfit for participation and was kindly thanked 
for their interest in participating. 
Approval for conducting the experiment was obtained from the Medical Ethical 
Committee of the University of Leuven (reference number ML8570). 
 
Esophageal Stimulation 
To prevent the catheter from moving due to peristaltic contractions of the esophagus that 
occur in response to balloon inflation, tape was used to gently attach the extraneous part of the 
catheter to the cheeks. The remainder of the catheter was draped over the ear and attached to 
an air filled syringe that was used for inflating the esophageal balloon.  
For this threshold determination, the volume of the balloon increased with 1 ml 
relative to each previous inflation. Between each 1 ml inflation, the balloon was deflated. 
Immediately after each inflation, subjects indicated whether they felt something, and rated 
what they felt on a scale from 0 to 10, with zero being no sensation at all, 1 indicating 
possibly a sensation (not being entirely certain), 2 indicating a sensation definitely being 
present but not yet painful, 8 being a clearly painful but still tolerable sensation, and 10 being 
the maximally tolerable intensity of pain. Participants were warned that intensity 10 would 
never be used, and that it was always possible to reduce the volume if the subjective intensity 
was too high. During threshold determination, up to and including intensity 3, the balloon was 
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inflated for 5 seconds, equaling the duration of the CS to be used in the experiment. Beyond 
this point on the scale, the balloon was inflated for 2 seconds only, which was the duration of 
the US to be used in the experiment. The entire threshold determination procedure was 
repeated a second time to make sure the thresholds were accurate. In case the second 
threshold determination yielded different results than the first, the thresholds obtained during 
the second determination were used as the first may be more prone to novelty effects. 
 
Subjective expectancy of US onset 
The position of the dial in the scale was digitally registered at 10Hz and transmitted via a data 
acquisition card to a computer throughout the entire experiment. The recorded digital values 
give an indication of the subjective estimation of each participant on how likely they felt they 
were to receive the US in the following seconds. As such, this dial can be used to assess 
whether participants learned to make correct predictions of US onset. 
 
Psychophysiological Measures 
All signals described below were recorded using Affect 4.0 software
1
 and transmitted via a 
16-Bit PCI-6221 data acquisition card (National Instruments, Austin, Texas) to a computer, 
and treated offline with Psychophysiological Analysis software (PSPHA)
2
. 
Eyeblink startle EMG 
The startle was elicited and measured as based on the guidelines of Blumenthal et al.
3
. A 
50ms burst of white noise with a volume of 102dB was used as an acoustic startle probe. The 
raw EMG signal was amplified by a LabLinc v75-04 Coulbourn Isolated Bioamplifier with 
Bandpass filter; the recording bandwidth was between 13Hz and 1 kHz. This signal was 
transmitted to a LabLinc v76-24 Coulbourn 4 Channel Integrator, which rectified and 
smoothed the signal online with a time constant of 20ms. The EMG signal was digitized at 
1kHz starting 500ms prior to onset of the acoustic probe, until 1000ms after probe onset. 
Galvanic Skin Response 
After cleaning the hypothenar side of the non-dominant hand with alcohol, two standard 
Ag/AgCl electrodes (diameter 1cm) filled with water-soluble KY*gel were attached here, 
spaced approximately 2.5cm apart. The galvanic skin response measured via these electrodes 
was transmitted to the LabLinc v71-23 Coulbourn Isolated Skin Conductance Coupler, which 
maintained a constant voltage of 0.5V over the electrodes; the analog signal was digitized at 
10Hz. 
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Study design 
Following the determination of the individualized thresholds for CS and US, electrodes for 
measuring startle and GSR were attached. Subjects were verbally informed what these 
electrodes would be used for, including information about the occurrence of acoustic startle 
probes throughout the experiment. Following electrode attachment, the intended use of the 
dial was explained to participants, and after they indicated they had no more questions, 
earphones were mounted on their head.  
Throughout the entire experiment, an experimenter remained in the lab with the 
participant in order to be able to administer the CS and US when required. Inflation and 
deflation of the esophageal balloon occurred outside the field of vision of the participant for 
both CS and US, by means of a manually operated air filled syringe. The experimenter 
administering the CS and US was cued to do so via a monitor, which was also placed outside 
the field of vision of the participant. On this monitor, a countdown occurred 5 seconds prior to 
inflation while indicating whether a CS or US had to be administered, and a second 
countdown occurred starting from onset of inflation, showing the remaining time till 
deflation. 
As the startle magnitude in response to the startle probe tends to be exaggerated upon 
initial presentation, and becomes more stable after repeated stimulation. Participants were first 
exposed to twelve startle probes, all administered with a fixed interval of ten seconds 
immediately prior to the onset of the actual experiment. After habituating to the probes, the 
participant started using the US expectancy dial and continued doing so until the end of the 
experiment. The dial was fixed in place within arm’s length in front of the participant. 
 
Response definition and statistical analysis 
Startle eye blink EMG 
EMG signals were visually inspected off-line to detect artifacts (e.g., excessive noise from 
muscular activity prior to the startle probe). Artifacts were rejected from analysis and defined 
as missing. The average percentage of rejected responses per participant was 8% (SD 6%). If 
responses to the probe were not visible, responses were classified as a non-response and set at 
zero. Five participants were excluded from the startle analysis because they either had more 
than 33% rejected responses, or had no visible response to the probe more than 66% of the 
time. All startle responses were T-transformed within persons to correct for interindividual 
variability that was unrelated to the experimental conditions of interest
3
. 
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Galvanic Skin Response 
After skin conductance responses were averaged across trials, skin conductance data were 
LOG10(1 + skin conductance response)-transformed before being analyzed. 
 
 
Results: Omnibus Test of Repeated Measure ANOVAs 
US-expectancy 
There was a main effect of Block F(4,200) = 9.45, p < .001, 2p = .16, ε = .86, a main effect 
of Time F(4,200) = 8.32, p < .001, 2p = .14, ε = .72 but no main effect of Group F(1,50) = .1, 
p = .8) and a trend towards significance for the Block × Group interaction F(4,200) = 2.06, p 
=  .099, 2p = .04, ε = .86. Furthermore, there was a significant Time × Group interaction 
F(4,200) = 8.87, p < .001, 2p = .15, ε = .72, and a significant Block × Time Interaction 
F(16,800) = 3.11, p = .001, 2p = .06, ε = .56. The Block × Time × Group interaction reached 
significance F(16,800) = 2.41, p = .011, 2p = .05, ε = .56.  
 
Galvanic Skin Response 
There was a main effect of Block F(4, 200) = 16.48, p < .001, 2p = .25, ε = .495 as skin 
responses habituated across blocks. Furthermore, there was a trend for stronger skin responses 
in the experimental group across blocks compared to the control group (Main effect of group: 
F(1,50) = 3.05, p = .087, 2p = .06. The interaction between Block and Group did not reach 
significance F(4,200) = 1.49, p = .23.  
 
Startle eye blink EMG 
There was a main effect of Block F(4,172) = 5.03, p = .005, 2p =.11, ε = .63, but no Block × 
Group interaction F(4,172) = 1.87, p = .15, ε = .63. There was a significant Stimulus × Block 
F(4,172) = 3.22, p = .014, 2p =.07 and a Stimulus × Group interaction F(1,43) = 7.93, p = 
.007, 2p =.16. The main effect of Stimulus F(1,43) = 3.58, p = .065, 
2
p =. 08 as well as the 
three-way interaction between Block × Stimulus × Group failed to reach significance F(4,172) 
= 2.05, p = .089,  2p =.05.  
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